Skip to Main Content

Paper Details

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.
Blood Cancer Discov
10
2023
AKT, B, CLL, CRISPR, Cas9, Chd2, E2F, MYC, Mga, PI3K, RS, Richter's syndrome, S6 kinases, Trp53, cancers, chronic lymphocytic leukemia, human, interferon, large cell lymphoma, mTOR, mice, murine, receptor phosphatase PTEN, transformed disease
Author NameAffiliation
Giorgio Inghirami
Gad GetzBroad Institute of MIT and Harvard
Gad GetzCancer Center and Department of Pathology, Massachusetts General Hospital
Gad GetzBroad Institute of MIT and Harvard
Gad GetzCancer Center and Department of Pathology, Massachusetts General Hospital
Donna NeubergDana-Farber Cancer Institute
Catherine J WuDana-Farber Cancer Institute
Catherine J WuHarvard Medical School
Catherine J WuBroad Institute of MIT and Harvard
Catherine J WuBrigham and Women's Hospital
  • 1 - 10

Datasets

Release 1.2